EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)

Integration of Remote Monitoring Into Palliative Care for Patients With Advanced Cancer Undergoing Phase I Therapies: A Randomized Clinical Trial

Integration von Remote Monitoring in die palliative Versorgung von Patient:innen mit fortgeschrittenem Krebs unter Phase-I-Therapien: randomisierte klinische Studie

David Hui iD, Ishwaria M Subbiah iD, David Hong, Penny Stanton, Jennifer Ellefson, Monawar Hosain, Josue Becerra, Vera de la Cruz iD, Amy Ontai iD, Ali Haider iD, Ethan Huang, Sanjay Shete iD und 1 weitere

JCO Oncology Practice · 2026-07 · 22 (7) · 1205-1215

DOI: 10.1200/op-25-00442 ↗

Auf einen Blick

Bei 100 Patient:innen verbesserte sich die Symptomlast unter SPC plus Remote Monitoring nach 2 Wochen; unter SPC allein nicht. Auch die gesundheitsbezogene Lebensqualität stieg unter SPC plus RM.

Fragestellung

Bringt zusätzliches Remote Monitoring zur ambulanten spezialisierten palliativmedizinischen Versorgung bei fortgeschrittenem Krebs mit Phase-I-Therapien einen Zusatznutzen bei Symptomlast und Lebensqualität?

Methode

Pilotstudie, parallelgruppig, einfach verblindet, randomisiert; 1:1 zu monatlicher SPC allein oder mit wöchentlichem RM zwischen den SPC-Terminen.

Ergebnisse

100 randomisiert (SPC+RM n=57; SPC n=43). Nach 2 Wochen: ESAS-GDS –5,0 (95 %-KI –8,9 bis –1,2) vs. –2,0 (95 %-KI –5,8 bis 1,8); FACIT-Sp 5,6 (95 %-KI 1,2 bis 10) vs. –1,1 (95 %-KI –7,3 bis 5,1).

Einschränkungen

Pilotstudie; Ergebnisse als vorläufig eingestuft; größere bestätigende Studien erforderlich.

Schlussfolgerung der Autor:innen

Die Autor:innen folgern, dass RM die SPC bei Patient:innen mit moderater bis hoher Symptomlast bei Symptomen und HRQOL verbessern könnte.

Kernaussagen

  • SPC plus RM zeigte nach 2 Wochen eine stärkere Verbesserung der Symptomlast
  • FACIT-Sp verbesserte sich unter SPC plus RM, nicht unter SPC allein
  • Die Autor:innen sehen die Befunde als vorläufig an

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JCO Oncology Practice, 2026-07. Verfasst von David Hui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Palliative Care, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Outpatient specialist palliative care (SPC) referral improves patient outcomes; however, it is unclear whether additional remote monitoring (RM) would provide further benefit. This pilot, parallel-group, single-blind, randomized clinical trial examined the within-group effect of monthly SPC alone or with additional weekly RM on symptom burden in patients with advanced cancer undergoing phase I therapies. METHODS Eligibility criteria included advanced solid tumor diagnosis and moderate-to-high symptom burden (ie, Edmonton Symptom Assessment System [ESAS] score ≥4/10 for ≥1 symptom and Global Distress Score [GDS] ≥20/90) before starting phase I therapies. Patients were randomly assigned 1:1 to either monthly outpatient SPC visits alone or with additional RM, consisting of weekly phone calls and concurrent electronic ESAS assessments between monthly SPC visits. The primary outcome was within-group change in symptom burden (ESAS-GDS) from baseline to 2 weeks; secondary outcomes included within-group change from baseline in ESAS-GDS and health-related quality of life (HRQOL; measured by Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being [FACIT-Sp]) over 12 weeks. RESULTS Between December 15, 2020, and December 21, 2022, 115 patients consented and 100 were randomly assigned (SPC + RM, n = 57; SPC, n = 43). The mean age (standard deviation) of analyzed patients was 56 (12) years, and 57 (64%) were female. At 2 weeks, SPC + RM had significant within-group improvement in ESAS-GDS (mean change, –5.0 [95% CI, –8.9 to –1.2]; P = .01) and FACIT-Sp (5.6 [95% CI, 1.2 to 10]; P = .01), but SPC alone did not (ESAS-GDS, –2.0 [95% CI, –5.8 to 1.8]; P = .29; FACIT-Sp, –1.1 [95% CI, –7.3 to 5.1]; P = .50). HRQOL improved significantly in SPC + RM compared with SPC at 12 weeks (14 [95% CI, 2.6 to 25]; P = .02). CONCLUSION Incorporating RM into SPC may improve symptoms and HRQOL beyond SPC alone for patients with moderate-to-high symptom burden. Our findings are considered preliminary and larger confirmatory trials are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareNeoplasmsHumansFemaleMaleMiddle AgedAgedQuality of LifeRemote Patient MonitoringSingle-Blind MethodSymptom BurdenPilot Projects

Autor:innen und Institutionen

  • Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sarah Cannon Research Institute, Nashville, TN.
  • Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas and MD Anderson Cancer Center, Houston, TX.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.

ORCID-Profile: David Hui, Ishwaria M Subbiah, Vera de la Cruz, Amy Ontai, Ali Haider, Sanjay Shete, Eduardo Bruera

Zitieren

APA

Hui, D., Subbiah, I. M., Hong, D., Stanton, P., Ellefson, J., Hosain, M., Becerra, J., de la Cruz, V., Ontai, A., Haider, A., Huang, E., Shete, S., & Bruera, E. (2026). Integration of Remote Monitoring Into Palliative Care for Patients With Advanced Cancer Undergoing Phase I Therapies: A Randomized Clinical Trial. JCO Oncology Practice, 22(7), 1205-1215. https://doi.org/10.1200/op-25-00442

Vancouver

Hui D, Subbiah IM, Hong D, Stanton P, Ellefson J, Hosain M, et al. Integration of Remote Monitoring Into Palliative Care for Patients With Advanced Cancer Undergoing Phase I Therapies: A Randomized Clinical Trial. JCO Oncology Practice. 2026;22(7):1205-1215. doi:10.1200/op-25-00442

BibTeX
@article{Hui2026,
  author = {Hui, David and Subbiah, Ishwaria M and Hong, David and Stanton, Penny and Ellefson, Jennifer and Hosain, Monawar and Becerra, Josue and de la Cruz, Vera and Ontai, Amy and Haider, Ali and Huang, Ethan and Shete, Sanjay and Bruera, Eduardo},
  title = {Integration of Remote Monitoring Into Palliative Care for Patients With Advanced Cancer Undergoing Phase I Therapies: A Randomized Clinical Trial},
  journal = {JCO Oncology Practice},
  year = {2026},
  volume = {22},
  number = {7},
  pages = {1205--1215},
  doi = {10.1200/op-25-00442}
}
Kostenlos starten →